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Ischemia–reperfusion injuryDeﬁcit in oxygen and energetic substrates delivery is a key factor in islet loss during islet transplantation. Perme-
ability transition pore (PTP) is a mitochondrial channel involved in cell death.We have studied the respective ef-
fects of oxygen and energy substrate deprivation on beta cell viability as well as the involvement of oxidative
stress and PTP opening. Energy substrate deprivation for 1 h followed by incubation in normal conditions led
to a cyclosporin A (CsA)-sensitive-PTP-opening in INS-1 cells and human islets. Such a procedure dramatically
decreased INS-1 cells viability except when transient removal of energy substrates was performed in anoxia, in
the presence of antioxidant N-acetylcysteine (NAC) or when CsA or metformin inhibited PTP opening. Superox-
ide production increased during removal of energy substrates and increased again when normal energy sub-
strates were restored. NAC, anoxia or metformin prevented the two phases of oxidative stress while CsA
prevented the second one only. Hypoxia or anoxia alone did not induce oxidative stress, PTP opening or cell
death. In conclusion, energy substrate deprivation leads to anoxidative stress followedbyPTPopening, triggering
beta cell death. Pharmacological prevention of PTP opening during islet transplantation may be a suitable option
to improve islet survival and graft success.
© 2015 Elsevier B.V. All rights reserved.Islet transplantation is a treatment to be considered for selected type
1 diabetic patients. The amount of engrafted islets is essential for islet
transplantation success, but unfortunately, 50–70% of the transplanted
islets are lost in the early post transplant period [1]. Among factors
responsible for poor islet graft, islet exposition to the ischemia–reperfu-
sion (I/R)7 phenomenon is important to consider. Normally, pancreatic
islets have a dense glomerular-like capillary network that is ideal for the
delivery of oxygen and nutrients [2,3]. During the isolation process and
in vitro culture, islets vasculature dedifferentiates or degenerates [4,5].
Immediately after transplantation into the portal vein (i.e., after embo-
lization in a capillary), islets are supplied with oxygen and nutrients
only by diffusion from the surrounding tissues. The revascularization
process is initiated within a few days, and islets are generally thought
to be fully revascularized by 15 days post transplant [6,7]. Meanwhile,
islets inevitably endure some restrictions in oxygen and nutrients.nergétique Fondamentale et
dex F-38041, France. Tel.: +33
che).Tissue ischemia is characterized by severe hypoxia, acidosis, energy
depletion and cell death. Excessive oxidative stress is well accepted as
an important component of I/R injury [8]: Reactive oxygen species
(ROS) production begins early in ischemia and is followed by a large
burst of oxidative stress during the ﬁrst few minutes of reperfusion
[9–11]. Although many details regarding the sources and targets of
oxidant stress during I/R injury are not known, a consensus as regards
the importance of ROS in I/R injury has emerged, based on studies
showing cell death protection during I/R by pretreatment with antioxi-
dants [12,13].
Other studies involved the mitochondrial permeability transition
pore (PTP) in I/R-induced cell death. The PTP is a Ca2+-sensitive mito-
chondrial inner membrane channel, which, on opening, causes cell
death [14,15]. Normally closed in order to allow ATP synthesis, perma-
nent PTP opening leads to a drastic ATP synthesis inhibition through
the collapse of the proton-motive force, a dramatic increase in ROS
production [16,17] and a release of mitochondrial pro-apoptotic
proteins (cytochrome c or AIF) [18], which results in cell death [19,
20]. It has been proposed that PTP remains closed during ischemia and
only opens with reperfusion [21] when the conditions for its opening
are present: ROS production, high mitochondrial [Ca2+], adenine
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Supporting a central role of PTP in I/R injury, several PTP inhibitors
(i.e., cyclosporin A (CsA), NIM811 or metformin) have been shown to
reduce cardiomyocytes, I/R-induced cell death or infarct size both in an-
imal and human models [24–29].
As regards pancreatic-derived cells, PTP opening has been shown
to be involved in cytokine [30], as well as high glucose and fructose-
induced apoptosis [31]. CsA has been shown to inhibit Ca2+-induced
PTP opening in INS-1 [31] and MIN-6 cells [32], to prevent PK11195-
induced cell death in isolated human pancreatic islets [33] and to
protect MIN-6 cells against Pdx1 insufﬁciency-induced cell death [34],
while genetic ablation of the endogenous PTP-inducers Cyclophilin D
prevents diabetes in Pdx1+/−mice [34]. The negative impact of I/R inju-
ry onhuman or dog islet viability iswell described [35,36]. However, the
involvement of oxidative stress and PTP opening in pancreatic I/R-
induced beta cell death has never been studied.
In the present study, we tested the effects of an O2 and energy sub-
strate deprivation on INS-1 cell viability. We next examined whether
PTP opening was involved in O2 and substrate deprivation-induced
cell death and whether CsA and metformin prevented INS-1 cell viabil-
ity after an O2 and energy substrate deprivation. Finally, we clariﬁed the
relationship between oxidative stress and PTP opening during O2 and
energy substrate deprivation and reproduced the effect of substrate
deprivation on PTP opening in human islets of Langerhans.
1. Materials and methods
1.1. Cell culture conditions
INS-1 cell linesweremaintained in RPMI 1640mediumsupplement-
ed with 10 mM HEPES, 10% heat-inactivated fetal calf serum, 2 mM L-
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 1 mM sodium
pyruvate and 50 mM 2-mercaptoethanol. Cells were incubated at
37 °C in a humidiﬁed atmosphere (95% air–5% CO2) [37].
1.2. Islets isolation and culture
Islets from pancreas of brain-dead multiorgan donors were isolated
as previously described according to amodiﬁed Ricordi method [38,39].
Brieﬂy, the pancreatic duct was catheterized and the pancreas was
distended by infusion of a cold collagenase solution (Collagenase NB1,
Serva Gmbh Heidelberg, Germany). After digestion (37 °C), a puriﬁca-
tion of cell suspension was performed in a continuous Biocoll gradient
(Biochrom AG, Berlin, Germany) using a refrigerated cell separator
(Cobe 2991 cell processor, Caridian BCT, France). In our experiments,
we handled islet preparations that could not be used for clinical islet
transplantation. Islets were provided by Geneva (Switzerland) or
Grenoble–Saint Ismier (France) cellular therapy centers and exhibited
a purity ranging from 30% to 70% as determined by dithizone staining.
After isolation, human islets were cultured at 37 °C, in a 5% CO2 atmo-
sphere, in Connaught’sMedical Research Labs (CMRL 1066-basedmedi-
um; SigmaAldrich) supplementedwith 10%decomplemented Fetal Calf
Serum, 25 mmol/L HEPES, 1 mM sodium pyruvate, 100 UI/ml penicillin
and 100 μg/ml streptomycin.
1.3. O2 and energy substrate deprivation procedure
O2 and energy substrate deprivation was achieved in a perfusion
chamber (POC chamber, LaCom®, Erbach, Germany) coupled with an
incubation system (O2-CO2-°C, PeCom®, Erbach, Germany) allowing a
variation of O2 from 0% to 21% thanks to N2 bubbling. The chamber
was mounted on a Leica TCS SP2 AOBS inverted laser scanning confocal
microscope. Under baseline conditions, cells previously incubated in the
absence or presence of 1 μM CsA for 1 h, 5 mM N-acetylcysteine (NAC)
for 1 h or 100 μMmetformin overnight were incubated in the standard
complete RPMI 1640 for INS-1 cells (Glucose = 11 mmol/L) orCMRL1066 for human islets of Langerhans (Glucose = 5.5 mmol/L)
under controlled O2 and CO2 conditions (95% air–5% CO2). Energy sub-
strate deprivation was achieved by replacing the normal complete
medium by a medium-deprived substrate (102.7 mM NaCl, 5.36 mM
KCl, 23 mM NaHCO3, 0.83 mM MgSO4, 5.65 mM Na2HPO4, 0.42 mM
Ca(NO3)2, 10mMHEPES). O2 deprivationwas achieved by equilibrating
the incubationmediawith either 3%O2, 5% CO2 and 92%N2 (hypoxia) or
5% CO2 and 95% N2 (anoxia). After 1 h, basal conditions were restored
by replacing the testedmediumby the normal completemedium equil-
ibrated with 95% air–5% CO2. Cells undergoing two changes of complete
RPMI 1640 medium equilibrated with 95% air–5% CO2 were used as
control.
1.4. Determination of PTP state by confocal microscopy
The open/closed PTP state was assessed by double channel imaging
of NAD(P)H autoﬂuorescence and mitochondrial electrical membrane
potential (i.e., TMRM ﬂuorescence) as recently described [40]. INS-1
cells set on collagen I-coated cover slips were studied by time-lapse
laser confocal microscopy at 37 °C in a humidiﬁed atmosphere (95%
air, 5% CO2) using a microscope equipped with a perfusion chamber
(POC chamber, LaCom®, Erbach, Germany) and an incubation system
(O2-CO2-°C, PeCom®, Erbach, Germany). Images were collected with a
Leica TCS SP2 AOBS inverted laser scanning confocal microscope
equipped with a Coherent 351–364 UV laser using a 63× oil immersion
objective (HCX PL APO 63.0 X 1.40). Laser excitation was 351–364 nm
for NAD(P)H and 543 nm for TMRM. Fluorescence emission adjusted
with AOBS was 390–486 nm for NAD(P)H and 565–645 nm for
TMRM. In order to allow the overlay of NAD(P)H and TMRM signals,
image acquisition was set with the same pinhole aperture (Airy 3.55),
necessarily increased because of the low signal of NAD(P)H autoﬂuores-
cence. To follow PTP status, NAD(P)H and TMRM ﬂuorescence images
were acquired every 10min during the simulated ischemia–reperfusion
procedure. Note that the changes of medium led to the removal of
TMRM outside the cells. This led to a release of TMRM from mitochon-
dria even when the electrical membrane potential remained constant.
To discriminate between this normal decrease in TMRM ﬂuorescence
and a real decrease in mitochondrial electrical membrane potential,
cells were reloaded with 10 nM TMRM, 15 min before the end of the
experiment. Experiments were performed on a randomly chosen ﬁeld
containing 15–25 cells. The background noise of NAD(P)H autoﬂuo-
rescence was removed by ﬁne ﬁlter (Kernel 3x3) using Volocity®
(Improvision) software, while the other images (TMRM and MitoSOX)
were not electronically manipulated. Image quantiﬁcation was per-
formed using ImageJ (NIH images) and Volocity® (Improvision) soft-
ware as described in [40].
1.5. Determination of adenine nucleotide content
INS-1 cells set on 100mmPetri dishes were exposed to O2 and ener-
gy substrate deprivation as described above using an O2 control cabinet
for in vitro studies (CoyLab®). At the end of the simulated ischemia and
1 h after the simulated reperfusion, samples of INS-1 cells were with-
held and lysed in ice-cold PCA (2.5%)-EDTA (6.25mM) for 5min. The in-
soluble material was eliminated by centrifugation at 12,000 g for 5 min,
and the supernatant fraction was immediately neutralized with KOH/
MOPS. After removal of the formed KClO4 by quick spin, the ﬁnal extract
was analyzed by HPLC as described in [41].
1.6. Quantiﬁcation of cell death by ﬂow cytometry
Cell viability analysis was performed with a double-stain system
using Annexin V (Interchim) combined with FluoProbes 488 and
propidium iodide (PI) (Sigma Aldrich). Forty-eight hours after a 1-h re-
moval of O2 and/or energy substrate, collected supernatant and cells de-
tached by trypsination were centrifuged. The cells were then incubated
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NaCl, 5 mM KCl, 1 mM MgCl2 and 1.8 mM CaCl2) for 15 min at room
temperature in the dark in the presence of 5 μl of Annexin V-FP488.
Cells were then transferred in a 5-ml propylene tube containing 900 μl
PBS and 10 μl of a 1-mg/ml stock solution of PI and immediately
analyzed. Data acquisition (~5,000 cells) was carried out using a BD
LSRFortessa™ cell analyzer (Becton-Dickinson Biosciences) equipped
with a 150-mW Coherent Compass laser (532 nm) and a 100-mW Co-
herent Sapphire laser (488 nm), using the BD FACsDiva™ software
(Becton-Dickinson Biosciences). Datawere plotted as a function of ﬂuo-
rescence intensity on 525/50 nm band-pass ﬁlter detector for Annexin
V-FluoProbes 488 and 585/15 nm band-pass ﬁlter detector for PI. The
Annexin V−/PI− population was regarded as normal healthy cells.
1.7. Assessment of oxidative stress
INS-1 cells incubated in the absence or presence of 1 μMCsA for 1 h,
5 mM NAC for 1 h or 100 μM metformin overnight were loaded for
15 min with 1 μM MitoSOX™ Red (Molecular Probes™), a cationic
probe distributing to the mitochondrial matrix by virtue of the mito-
chondrial transmembrane potential. The probe becomes highly ﬂuores-
cent after oxidation by superoxide in the presence of DNA. To followFig. 1.Respective effects of oxygen and energy substrate deprivation on INS-1 cell viability. INS-
100 μMmetformin overnight were submitted to the indicated conditions of incubation for 1 h
beling as described in theMaterials and Methods section. Histograms represent the results of th
periments. Values not connected by the same letter are signiﬁcantly different (Tukey–Krameroxidative stress, MitoSOX™ Red ﬂuorescence images were acquired
every 10 min during the procedure. Laser excitation was 514 nm. Fluo-
rescence emission adjusted with AOBS was 550–630.
1.8. Statistics
Results are presented as mean ± SEM. The statistical signiﬁcance of
differences was analyzed by a one-way ANOVA followed by the Tukey–
Kramer HSD post hoc test or by the Dunnett test using JMP® (SAS) soft-
ware. Signiﬁcance was deﬁned as p b 0.05.
2. Results
2.1. Effects of energy substrate withdrawal on INS-1 cell viability
Assuming that oxygenmay diffuse better than the energy substrates
inside the islets once they have been embolized in a capillary, INS-1 cells
were exposed for 1 h in a medium without energy substrates (see
Materials and Methods section) with either 20% O2 (95% air–5% CO2),
3% O2 (hypoxia) or no O2 (anoxia). As shown in Fig. 1, 48 h after such
a procedure, INS-1 cells incubated without energy substrates in the
presence of either 20% or 3% O2 exhibited a dramatic alteration in1 cells incubated in the absence or presence of either 1 μMCsA for 1 h, 5mMNAC for 1 h or
and then incubated in normal conditions for 48 h. Cell viability was assessed by double la-
ree different experiments. Results are presented asmean± SEM of at least 3 different ex-
HSD post hoc test, p b 0.0001).
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energy substrates in the absence of O2 did not induce cell death. More-
over, INS-1 cells exposed for 1 h in a medium with energy substrates
but in the absence of O2 or in the presence of 3% O2 did not undergo
cell death, indicating that INS-1 cells can survive for an hourwith no ox-
ygen. Interestingly, cell death induced by a 1-h withdrawal of energy
substrates was prevented by either CsA or metformin, which have
been shown to inhibit PTP opening in INS-1 cells [31], and by antioxi-
dant NAC.
2.2. Effects of energy substrate withdrawal on PTP state
To test whether the removal of energy substrates led to PTP opening
as suggested by the preventive effect of CsA or metformin on cell viabil-
ity, PTP status was assessed by double channel imaging of NAD(P)H au-
toﬂuorescence and mitochondrial electrical membrane potential
(i.e., TMRM ﬂuorescence) as recently described [40]. Brieﬂy, when PTP
is closed, NAD(P)H is mainly localized within mitochondria and co-
localizes with TMRM ﬂuorescence (which accumulates in polarized mi-
tochondria). Permanent PTP opening leads to a dramatic collapse in
membrane potential associated with an increase in NAD(P)H autoﬂuo-
rescence both in terms of intensity and intracellular distribution.
Using this method, every 10 min, we measured the INS-1 NAD(P)H
and TMRM ﬂuorescence submitted to control conditions or to O2 and
energy substrate deprivation procedures. Note that the same micro-
scope settings were kept through the entire procedure. As shown in
Fig. 2, under control conditions, NAD(P)H remained stable while
TMRM ﬂuorescence slightly decreased due to TMRM dilution caused
by medium changes but increased after TMRM reload at the end of re-
perfusion. On the contrary, after the removal of energy substrates in
the presence of 3% O2, both NAD(P)H area and intensity drastically di-
minished (most probably due to the consumption of endogenous sub-
strates, see below) then slightly increased (but remained lower than
control), while TMRM ﬂuorescence slightly decreased in a way not sig-
niﬁcantly different from what observed in the control conditions. After
the restoration of O2 and energy substrates, NAD(P)H area and ﬂuores-
cence continuously increased, reaching valuesmore than twice the con-
trol, whereas TMRM ﬂuorescence dramatically decreased, with no
recovery after TMRM reload.
In parallel experiments, the adenine nucleotide content was mea-
sured at the end of the deprivation procedure and 1 h following the res-
toration of normal condition of incubation. As shown in Fig. 2, the ATP/
ADP ratio remained constant during time in the control experiment.
Interestingly, the ATP/ADP ratio slightly decreased 1 h after the removal
of energy substrates in the presence of 3% O2, whereas it collapsed 1 h
after the restoration of O2 and energy substrates, as expected in cells
with depolarized mitochondria.
Normally, mitochondrial depolarization is expected to increase
NADH consumption by the respiratory chain and therefore to decrease
the NAD(P)H ﬂuorescence. In cells in which this prediction was con-
ﬁrmed (HMEC-1 cells, isolated hepatocytes, primary neurons and pri-
mary astrocytes [40,42]), the counterintuitive increase in NAD(P)H
ﬂuorescence concomitant with mitochondrial depolarization is most
probably due to the reduction of the cytosolic NAD+ pool by the TCA
cycle made possible by the diffusion of pyridine nucleotides through
the open PTP, a phenomenon reproduced in isolated mitochondria
when PTP opening occurs in the presence of NAD+ [40].
Unexpectedly, as shown in Fig. 3, mitochondrial uncoupling did not
collapse NAD(P)H ﬂuorescence in INS-1 cells. Actually, uncoupling only
transiently decreased NAD(P)H ﬂuorescence, which eventually in-
creased when mitochondria were fully depolarized. Note that CsA did
not prevent this behavior (not shown). Independently of the putative
explanation of this observation (see discussion), any increase in
NAD(P)H ﬂuorescence concomitant with mitochondrial depolarization
cannot be considered as speciﬁc to PTP opening in INS-1, unless it is to-
tally prevented by PTP inhibitors.Therefore, the same assessment of NAD(P)H and TMRM ﬂuores-
cence by confocal microscopy was performed in all the conditions test-
ed in Fig. 1, including incubation in the presence of PTP inhibitors.
Results are presented in Fig. 4 as the overlay of the NAD(P)H and
TMRM ﬂuorescence. For an easier comparison the overlays of Fig. 2
are presented in Fig. 4A and B.
As shown in Fig. 4C, when cells were incubated with 3% O2 in the
presence of energy substrates (normal complete medium), no changes
in NAD(P)H intensity and area were observed, while TMRM ﬂuores-
cence was the same as in control conditions after TMRM reload. Exactly
the same behavior was observed when the medium without energy
substrates (see Materials and Methods section) was supplemented
with 11 mM Glucose (data not shown).
On the contrary, the samedramatic increase and decrease inNAD(P)H
andTMRMﬂuorescence respectivelywasobservedwhen the1-h removal
of energy substrates was performed in normoxia (Fig. 4D). These data
suggested that the absence of energy substrateswasmandatory to induce
such a behavior.
Importantly, this behavior did not occur when PTP opening was
prevented by either CsA (Fig. 4E and F) ormetformin (Fig. 4G), whereas
it was not prevented by verapamil (not shown), which does not affect
PTP regulation but inhibits ABC transporter as CsA does [43]. Together,
these data strongly suggested that the removal of energy substrates in
the presence of O2 (20% O2 or 3% O2) led to permanent PTP opening
after energy substrate restoration in INS-1 cells. Interestingly, antioxi-
dant NAC (which does not directly inhibit PTP opening) also prevented
mitochondrial depolarization and the increase in NAD(P)H ﬂuorescence
after O2 and energy substrate restoration (Fig. 4H), suggesting that PTP
opening was triggered by an oxidative stress during our experimental
protocol.
As expected, theNAD(P)Hﬂuorescencedramatically increasedwhen
cells were incubated in anoxia in the presence of energy substrates
(Fig. 4I). At the same time, TMRM ﬂuorescence decreased. After O2 res-
toration, the NAD(P)H ﬂuorescence became normal again while the
TMRM ﬂuorescence remained low. This was due to the removal of
TMRMoutside the cells during the changes ofmediumpreventingmito-
chondria from taking up TMRM as demonstrated by a large uptake of
TMRM after TMRM reloading. The same changes in NAD(P)H ﬂuores-
cence were observed in the absence of TMRM (data not shown).
When cells were incubated in anoxia deprived of energy substrates
(Fig. 4J), NAD(P)H remained stable (due to a lack of O2which prevented
the consumption of the remaining substrates). After O2 and energy sub-
strate restoration, the NAD(P)H ﬂuorescence ﬁrst decreased and then
slightly increased but remained lower thanwhat observedwhen the re-
moval of energy substrates was performed in hypoxia, while TMRM
ﬂuorescence was the same as in control conditions after TMRM reload.
These data suggested that the presence of O2 during the removal of en-
ergy substrates was mandatory to induce PTP opening.
2.3. Relationship between PTP opening and oxidative stress during O2 and
energy substrate deprivation procedure
To assess superoxide production during O2 and energy substrate
deprivation procedures, INS-1 cells loaded 15 min with MitoSOX™
Red were imaged every 10 min. After the removal of energy substrates
in the presence of O2 (20% O2 or 3% O2), a signiﬁcant increase in oxida-
tive stress was detected as compared with the control conditions
(Fig. 5). This ﬁrst oxidative stress was followed by a burst in ROS pro-
duction observed after energy substrate restoration. Note, however,
that the second oxidative stress was delayed and therefore not related
to changes in oxygen concentration as it occurred when cells were con-
tinuously incubated in the presence of 20%O2, while it was not synchro-
nous with the normalization of O2 concentration when cells had
undergone a 1-h exposure to 3% O2. Note, moreover, that during this
second oxidative stress, the ﬂuorescence increased notably in some
cells (presumably those that have undergone PTP opening, see below).
Fig. 2. Respective effects of oxygen and energy substrate deprivation on NAD(P)H autoﬂuorescence, mitochondrial electrical membrane potential and ATP/ADP ratio. INS-1 cells loaded
with 10 nMTMRM for 1 hwere incubated in normal conditions (substrates and 20% O2) or submitted to hypoxia (3% O2) without energy substrates for 60min, followed by the restoration
of normal conditions of incubation for 60min. The ﬂuorescence of NAD(P)H (pseudo color green) and TMRM (pseudo color red) were imaged every 10min during the simulated I/R pro-
cedure. Image quantiﬁcation (arbitrary units (AU)) was performed as described in theMaterials andMethods section. Curves represent the results of three different experiments. Results
are presented asmean± SEM of at least 3 different experiments. Open symbols, control; closed symbols, simulated I/R; arrow, TMRM reload. The ATP and ADP content weremeasured in
parallel experiments at the end of the deprivation procedure and1h following the restoration of normal condition of incubation. Results are presented asmean±SEMof at least 3 different
experiments. Grey, control; black, simulated I/R. Values not connected by the same letter are signiﬁcantly different (Tukey–Kramer HSD post hoc test, p b 0.0001).
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suggesting a diffusion of either superoxide or ethidium (the oxidized
form of the dihydoethidiummoiety of the MitoSOX™) from mitochon-
dria to the nucleus.As shown in Fig. 5, the second oxidative stress was totally prevented
by all the conditions that prevented PTP opening (namely CsA, metfor-
min, NAC, incubation in anoxiawithout energy substrates, or incubation
in the presence of 3% O2 with energy substrates), indicating that the
Fig. 3. Effects of FCCP on NAD(P)H autoﬂuorescence and mitochondrial electrical membrane potential. INS-1 cells loaded with 10 nM TMRM for 1 h were incubated in normal conditions
(substrates and 20%O2) and exposed to 50 μMFCCP. Theﬂuorescence of NAD(P)H (pseudo color green) and TMRM(pseudo color red)were imaged every 5min. Result representative of 3
different experiments.
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(which is not an antioxidant) did not prevent the ﬁrst oxidative stress,
whereas NAC, anoxia without energy substrates or incubation in the
presence of 3% O2 with energy substrates prevented the ﬁrst oxidative
stress. Interestingly, metformin also prevented the ﬁrst oxidative stress.
2.4. Effects of energy substrate withdrawal on human islets of Langerhans
Due to the extreme scarcity of human islets of Langerhans, a com-
plete reproduction of the above results was not possible. However, as
shown in Fig. 6, a 1-h removal of energy substrates in the presence of
3% O2 led to a similar CsA-sensitive increase and decrease in NAD(P)H
and TMRM ﬂuorescence respectively after the restoration of O2 and en-
ergy substrates.
3. Discussion
In this work, we have reported that a 1-h removal of energy
substrates in INS-1 cells led to cell death via PTP opening only if an ox-
idative stress occurred during the deprivation of energy substrates. In
agreement with what is generally reported during I/R injuries, we also
observed a robust oxidative stress after the restoration of energy sub-
strates, yet this was not the cause but the consequence of PTP opening.
The involvement of PTP opening in I/R is sustained by a large number
of studies that have reported a beneﬁcial effect of PTP inhibition on in-
farct size. However, none of these studies have directly visualized PTP
opening during I/R or analyzed the respective effect of substrate or O2
deprivation. Here, we show that the deprivation of energy substrates
for 1 h—but not the deprivation of O2 for the same period of time—
was responsible for a CsA-sensitive mitochondrial depolarization
(i.e., PTP opening) in beta cells.
Thismay not be a general rule for other types of cells. Note, however,
that PTP opening-induced cell death has been reported in brain suffer-
ing hypoglycemia [44]. In beta cells, insulin secretion strongly depends
on the ATP concentration, which is directly modulated by glucose avail-
ability. In order to respond quickly to changes in blood glucose concen-
tration, these cells have no glycogen reserves. The same absence ofglycogen reserves can be noted in neurons, which probably explains
why these cells are so sensitive to substrate removal.
In normal cells, when anaerobic glycolysis is stimulated, NADH does
not accumulate because the lactate dehydrogenase regenerates NAD+
when pyruvate is converted into lactate; this latter being released via
the monocarboxylate transporter. In beta cells, the lactate dehydroge-
nase activity is very low [45] and the monocarboxylate transporter is
not expressed [46]. Although a low amount of monocarboxylate trans-
porter has been reported in INS-1 cells [47], the unusual dramatic in-
crease in NAD(P)H signal observed when INS-1 cells are incubated
with substrates in the absence of O2 suggests that lactate dehydroge-
nase and the monocarboxylate transporter activities remain lower
than the production of NADH by glycolysis. This may also explain the
unusual increase in NAD(P)H ﬂuorescence following mitochondrial
uncoupling observed in Fig. 3, the NADH produced by glycolysis in the
cytosol being unable to enter mitochondria via the electrogenic ma-
late/aspartate shuttle while the PTP remains closed.
On the contrary, complex I can theoretically consume the cytosolic
NADH after PTP opening, unless the respiratory chain is inhibited. We
have previously demonstrated that PTP opening partly inhibits complex
I activity in isolated mitochondria [48] and inhibits oxygen consump-
tion in intact cells [40]. Additional explanation for an inhibition of respi-
ratory chain after PTP opening includes the release of cytochrome c and
the exhaustion of O2. However, considering the exchange area between
medium and air in our device on the one hand, and the fact that super-
oxide production increased on the other hand, this latter hypothesis
seems unlikely. In addition to the NADH produced by glycolysis, the
TCA cycle can produce NADH from the cytosolic NAD+ pool [40],
which can diffuse inside mitochondria after PTP opening.
In our hands, INS-1 cells incubated in the presence of substrates but
in the absence of oxygen died after 6 h (data not shown). This does not
mean that the cells function properly for 6 h but indicates that they can
survive for 6 h thanks to anaerobic glycolysis. Assuming that human is-
lets of Langerhans are totally deprived of monocarboxylate transporter,
their survival in the absence of oxygen is probably shorter.
It has been previously shown that the deprivation of O2 and energy
substrates causes a ﬁrst oxidative stress during deprivation [9,10,49],
635S. Lablanche et al. / Biochimica et Biophysica Acta 1847 (2015) 629–639followed by a second one after O2 and energy substrate restoration.
However, the origin of these two oxidative stresses remains elusive. Mi-
tochondria are the main source of oxidative stress in cells. Superoxide
can be generated both at respiratory chain complexes I and III [50].
Complex I is a reversible proton pump that can generate superoxide
during forward and reverse electron ﬂux [51,52]. Complex I inhibitors
increase superoxide production driven by a forward electron ﬂux,
whereas they decrease superoxide production driven by a reverseFig. 4. Effects of CsA, metformin, NAC and anoxia on energy substrate deprivation-induced PTP
NAC for 1 h or 100 μMmetformin overnight loadedwith 10 nM TMRM for 1 h were submitted
incubation for 60 min. The ﬂuorescence of NAD(P)H (pseudo color green) and TMRM (pseudo
merged. Image quantiﬁcation was performed as described in the Materials and Methods sect
mean ± SEM of at least 3 different experiments. Blue symbols, NAD(P)H; red symbols, TMRMelectron ﬂux. Metformin, which partly inhibits complex I [53], has
been shown to decrease superoxide production driven by a reverse
electron ﬂux [16]. Therefore, the observation that metformin dramati-
cally decreased theﬁrst oxidative stress (see Fig. 5) suggests that the ox-
idative stress during the deprivation procedure was due to a reverse
electron ﬂux at complex I.
Theoretically, the production of superoxide is impossible in the total
absence of O2, while antioxidants are expected to hamper oxidativeopening. INS-1 cells incubated in the absence or presence of either 1 μMCsA for 1 h, 5 mM
to the indicated conditions for 60 min, followed by the restoration of normal conditions of
color red) were imaged every 10 min during the procedure, and the two channels were
ion. Curves represent the results of three different experiments. Results are presented as
; arrow, TMRM reload.
Fig. 4 (continued).
636 S. Lablanche et al. / Biochimica et Biophysica Acta 1847 (2015) 629–639stress. As shown in Fig. 5, superoxide production during the removal of
energy substrates was prevented by incubating cells either in anoxia or
in the presence of NAC. The fact that the prevention of superoxide pro-
duction during energy substrate removal totally prevented PTP opening
and cell death strongly suggests that the oxidative stress during energy
substrate deprivation was critical for PTP opening and cell death.
Whether PTP opening occurs during ischemia or only at reperfusion
remains debated and may depend on the model used. In the present
work, mitochondrial depolarization associated with the increase in
NADH ﬂuorescence did not occur during the simulated ischemia (dur-
ing the deprivation of energy substrates or O2).Although oxidative stress is well known to favor PTP opening [15],
the exact mechanism by which an oxidative stress during simulated
ischemia is a prerequisite for PTP opening after simulated reperfusion
remains unknown. Note that mitochondrial depolarization and the
increase in NAD(P)H ﬂuorescence (i.e., PTP opening) preceded the sec-
ond oxidative stress (compare Fig. 4 with Fig. 5). It has been reported
that PTP opening stimulates ROS production in intact cells [17], and
we have shown in isolated mitochondria that such production occurs
at complex I and depends on NADH concentration [48]. Assuming that
the same mechanism occurs in intact cells, and taking into account
that NAD(P)H concentration was low just after PTP opening but
Fig. 5. Effects of oxygen, energy substrates, CsA, metformin and NAC on superoxide production. INS-1 cells incubated in the absence or presence of 1 μM CsA for 1 h, 5 mMNAC for 1 h or
100 μMmetformin overnight, loadedwith 1 μMMitoSOX™ Red for 15min, were submitted to the indicated condition for 60min, followed by the restoration of normal conditions of in-
cubation for 60 min. The ﬂuorescence of MitoSOX™ Redwas imaged every 10 min during the procedure. Image quantiﬁcation was performed as described in the Materials and Methods
section. Results are presented as mean ± SEM of at least 3 different experiments. Histograms represent the superoxide production (calculated by ﬂuorescence subtraction: FT60-FT0 or
FT120-FT60) during the studied condition (grey) and after normal conditions were restored (black). * and # signiﬁcantly different from control during the same period (* from T0 to
T60; # from T60 to T120) (Dunnett’s test, p b 0.05).Values not connected by the same letter are signiﬁcantly different (Tukey–Kramer HSD post hoc test, p b 0.05).
637S. Lablanche et al. / Biochimica et Biophysica Acta 1847 (2015) 629–639increasedwith time (Fig. 4), it is expected that PTP opening does not in-
duce superoxide production until NADH concentration increases. In ad-
dition, the second oxidative stress may be exacerbated by the loss of
cytochrome c, which has been shown to be a powerful superoxide scav-
enger in its oxidized form [54].
Although substantial progress has been made on islet isolation and
immunosuppression protocols [55], obstacles still compromise islet
transplant success. A waste of islets occurs during the isolation proce-
dure, while 50% to 70% of islets are estimated to be destroyed in the im-
mediate post transplant period [1],making beta cell death a crucial issue
that prevents islet transplantation from spreading. Among several fac-
tors, this work suggests that islet viability may be compromised by a
lack of energy substrates during isolation procedures or after engraft-
ment. This point should be underlined sincemost cold storage solutions
used for organ conservation are deprived of energy substrate.
It has been shown that immunosuppressive drugs (including CsA)
impair insulin secretion [56], partly by inhibiting insulin gene tran-
scription [57]. However, if high concentration of CsA (5 μg/ml, i.e., ap-
proximately 4 μM) has been shown to be toxic for pancreatic islets,
therapeutic dose of CsA (1 μg/ml, i.e., approximately 0.8 μM) did not af-
fect pancreatic islets viability [58],which is consistentwith the results in
Fig. 1. If long-term administration of high concentrations of CsA should
to be detrimental for islet functionality, the transient use of therapeutic
dose of CsA restricted to the early post-transplantation period might be
a suitable option to consider in order to preserve islet graft viabilityduring this particular vulnerability period. Since a lack of energy sub-
strates leads to cell death due to PTP opening, preventing PTP opening
during the entire islet transplant proceduremay enhance beta cells sur-
vival and improve islet transplant outcome. Further in vivo studies are
necessary to conﬁrm that the prevention of PTP opening does improve
islet survival and islet graft success.Abbreviations
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Fig. 6. Effects of simulated hypoxia reperfusion on PTP status in human islets of Langerhans. Human islets of Langerhans incubated in the absence or presence of 1 μM CsA for 1 h loaded
with 10 nM TMRM for 1 h were submitted to the indicated conditions for 60min, followed by the restoration of normal conditions of incubation for 60 min. The ﬂuorescence of NAD(P)H
(pseudo color green) and TMRM (pseudo color red) were imaged every 10 min during the procedure and the two channels were merged. Curves represent the results of three different
experiments. Results are presented as mean ± SEM of 3 different experiments. Blue symbols, NAD(P)H; red symbols, TMRM; arrow, TMRM reload.
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